Source: Clujul Medical. Sep, Vol. In this study we analyzed the profile of resistance to suitable antibiotics for isolates of Escherichia coli 71 isolates and Klebsiella pneumoniae 84 isolates producing extended-spectrum beta-lactamases ESBLs.
Au fost necesare două luni și trei cicluri de tratament cu antibiotice diferite pentru ca infecția să fie tratată cu succes. Nimeni nu știe de unde a contractat Paolo infecția.
Material and methods. The isolates were collected over a period of three years and four months January April The sensitivity to antibiotic has been tested using the system Vitek2 Compact and antimicrobial disk wart on foot kid method.
ESBL isolates of Escherichia coli and Klebsiella pneumoniae studied presented multiple resistance to antibiotics, especially to aminoglycosides, quinolones and trimethoprim-sulfamethoxazole. To stop the spread of bacterial strains resistant to antibiotics requires detailed knowledge of the mechanisms of bacterial resistance in parallel with the development and implementation of hospital policies for prescriptions of antibiotics, financial requirements bacterii esbl by antimicrobial bacterii esbl and the additional measures on control of microorganisms that can cause nosocomial infections.
English Copyright of Clujul Medical is the property of Cluj Medical University and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.
This abstract may be abridged. No warranty is given about the accuracy of the copy.
Users should refer to the original published bacterii esbl of the material for the full abstract. Important User Information: Remote access to EBSCO's databases is permitted to patrons of subscribing institutions accessing from remote locations for personal, non-commercial use.
However, remote access to Bacterii esbl databases from non-subscribing institutions is not allowed if the purpose of the use is for commercial gain through cost reduction or avoidance for a non-subscribing institution.